Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study
暂无分享,去创建一个
H. Ohno | M. Murakami | Takeshi Takahashi | S. Sakajiri | K. Matsue | T. Sakura | K. Usuki | S. Ohwada | R. Imanaka | Taiga Takagi